NIH National Neurology Advisory Council Gains Five New MembersFriday, Oct 12, 2007
The National Institute of Neurological Disorders and Stroke (NINDS) welcomes five new members to its National Advisory Neurological
Disorders and Stroke Council. The Council serves as the principal advisory body to the NINDS, a component of the National
Institutes of Health and the nation's primary supporter of basic, translational, and clinical research on the brain and nervous
system.
Drug Screening Study Suggests New Treatments for Alzheimer'sMonday, Sep 26, 2005
While several treatments are currently available for Alzheimer's disease (AD), none of them can slow or halt the course of
this devastating disorder. In a new study, researchers have now identified three compounds that inhibit an enzyme believed
to be involved in the process that leads to AD. This discovery may lead to new treatments that can stop the disease process
in its tracks.
NIH Scientists Identify Gene for Fatal Childhood Disorder, Niemann-Pick Type C: Finding Points to Critical New Steps in Cholesterol
ProcessingThursday, Jul 10, 1997
Bethesda, MD -- After decades of work, scientists at the National Institutes of Health have identified a gene alteration associated
with the fatal childhood cholesterol disorder Niemann-Pick type C (NPC). Learning how the gene functions may lead to the
first effective treatment for the disease and to a fundamental new understanding of how cholesterol is processed in the body.
Scientists Link Fatal, Cholesterol-Storage Disorder to Chromosome 18Monday, Mar 1, 1993
Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) have linked a deadly brain disorder, called
Niemann-Pick Type C disease, to a small region of human chromosome 18. These findings, reported in the current issue of Proceedings
of the National Academy of Sciences,* may eventually lead to improved diagnosis and treatment for this inherited disorder
and yield new insight into the metabolism of cholesterol inside the body's cells.